Interests

  • Gene Therapy

  • Neuroscience

  • Molecular Biology

  • Vector Delivery

Adam Falah

Ph.D. Candidate

Adam is a Ph.D. student at the University of Waterloo School of Pharmacy, co-supervised by Dr. Roderick Slavcev & Dr. Mike Beazely. He completed his M.Sc. at Queen’s University where his research focused on the robotic assessment of processing speed and longitudinal cognitive changes in epilepsy. His current research focuses on using anellovirus-based vectors to reprogram astrocytes to neurons as a novel therapeutic approach for neurodegenerative diseases as part of the iNeuron project. By utilizing engineered bacteriophage-based vectors for targeted gene delivery, his work aims to overcome current challenges in gene therapy and provide a potential strategy for neuronal regeneration.

Education

  • B.Sc. Biology, Neuroscience Specialization, Lakehead University (2022)

  • M.Sc. Neuroscience, Queen’s University (2024)

Contact

  • adam.falah@theraphage.bio

  • adam.falah@uwaterloo.ca


PUBLICATIONS:

Presentations:

  • Falah, A. Robotic Assessment of Processing Speed Impairments in Epilepsy. Presented at:

    • XXVI World Congress of Neurology, Montreal, Quebec, Canada, 2023

    • Kinarmpalooza, Kingston, Ontario, Canada, 2023.

  • Falah, A. Robotic Assessment of Cognitive Deficits in Epilepsy. Presented at: Epilepsy Southeastern Ontario Conference, Kingston, Ontario, Canada, 2023.

  • Falah, A. The Cognitive Profiles of Temporal Lobe Epilepsy (TLE). Presented at: Brainstorm Series, Kingston, Ontario, Canada, 2023.